Real-World Evidence of Long-Term Disease Control in HER2-Positive Metastatic Breast Cancer Patients Treated with a First-Line Combination of Trastuzumab and/or Pertuzumab Plus Chemotherapy.
Saved in:
| Title: | Real-World Evidence of Long-Term Disease Control in HER2-Positive Metastatic Breast Cancer Patients Treated with a First-Line Combination of Trastuzumab and/or Pertuzumab Plus Chemotherapy. |
|---|---|
| Authors: | Chaigneau, Loïc1 (AUTHOR) lchaigneau@chu-besancon.fr, Lapp, Eva2 (AUTHOR), Jai, Taha2,3 (AUTHOR), Dobi, Erion1,4 (AUTHOR), Martin, Berenger3 (AUTHOR), Curtit, Elsa1,4 (AUTHOR), Nerich, Virginie2,4 (AUTHOR) |
| Source: | Cancers. Nov2025, Vol. 17 Issue 21, p3532. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers17213532 |
